Related Experiment Video

Updated: May 16, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Nanoformulation of natural products for prevention and therapy of prostate cancer

Vanna Sanna1, Imtiaz A Siddiqui2, Mario Sechi1

  • 1Department of Dermatology, University of Wisconsin, Madison, WI, USA; Department of Chemistry and Pharmacy, Laboratory of Nanomedicine, University of Sassari, Italy.

Cancer Letters
|December 4, 2012
PubMed

Insights

Developing new prostate cancer treatments using nanotechnology to deliver natural compounds shows promise. This approach aims to inhibit cancer growth and enhance existing therapies for better patient outcomes.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Prostate cancer requires improved therapeutic options to inhibit lesion proliferation and enhance current treatments.
  • Natural compounds are being explored for their potential in prostate cancer chemoprevention and chemotherapy.
  • Nanotechnology offers novel strategies for targeted delivery of these natural compounds.

Purpose of the Study:

  • To review promising natural compounds for prostate cancer management.
  • To discuss the current state of nanotherapeutics, including nanochemoprevention.
  • To highlight the clinical development of targeted nanoprototypes for prostate cancer treatment.

Main Methods:

  • Literature review of natural compounds with chemopreventive and chemotherapeutic potential for prostate cancer.
  • Analysis of current nanotherapeutic strategies and nanochemoprevention concepts.
  • Examination of clinical development data for targeted nanoprototypes in prostate cancer therapy.

Main Results:

  • Several natural compounds demonstrate significant potential for prostate cancer chemoprevention and chemotherapy.
  • Nanotherapeutics, including nanochemoprevention, represent a promising frontier in disease management.
  • Targeted nanoprototypes are advancing towards clinical application for prostate cancer treatment.

Conclusions:

  • Nanotechnology-based delivery of natural compounds offers a promising strategy for improved prostate cancer therapeutics.
  • Further research and clinical development of nanochemoprevention and targeted nanoprototypes are crucial.
  • This approach holds potential to inhibit cancer progression and improve treatment efficacy.

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...